Eisai

E24939

multinational corporation pharmaceutical company public company

Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.

Try in SPARQL Jump to: Surface forms Statements Referenced by

All labels observed (1)

Label	Occurrences
Eisai canonical	10

Predicate	Object
instanceOf	multinational corporation ⓘ pharmaceutical company ⓘ public company ⓘ
collaboratesWith	Biogen ⓘ other global pharmaceutical companies ⓘ
country	Japan ⓘ
developed	Donepezil ⓘ surface form: Aricept Donepezil ⓘ Leqembi ⓘ surface form: Lecanemab Leqembi ⓘ
developedForIndication	Aricept – Alzheimer’s disease ⓘ Donepezil ⓘ surface form: Donepezil – Alzheimer’s disease Lecanemab – Alzheimer’s disease ⓘ Leqembi ⓘ surface form: Leqembi – Alzheimer’s disease
engagesIn	clinical trials ⓘ drug development ⓘ drug discovery ⓘ
focusesOn	Alzheimer’s disease ⓘ cancer ⓘ neurology ⓘ oncology ⓘ
foundedIn	Japan ⓘ
hasProduct	Donepezil ⓘ surface form: Aricept Donepezil ⓘ Leqembi ⓘ surface form: Lecanemab Leqembi ⓘ
hasResearchArea	immuno-oncology ⓘ neurodegenerative diseases ⓘ oncology therapeutics ⓘ
hasTherapeuticArea	central nervous system disorders ⓘ epilepsy ⓘ hematologic malignancies ⓘ solid tumors ⓘ
headquartersLocation	Japan ⓘ Tokyo ⓘ
industry	biotechnology ⓘ pharmaceutical industry ⓘ
knownFor	Alzheimer’s disease therapies ⓘ neurology products ⓘ oncology products ⓘ
listedOn	Tokyo Stock Exchange ⓘ
operatesIn	Asia ⓘ Europe ⓘ North America ⓘ global markets ⓘ
specializesIn	prescription drugs ⓘ research and development ⓘ
tickerSymbol	4523 ⓘ

Full triples — surface form annotated when it differs from this entity's canonical label.

Biogen → collaboratesWith → Eisai ⓘ

Leqembi → developedBy → Eisai ⓘ

Leqembi → hasBrandOwner → Eisai ⓘ

Aduhelm → coDevelopedBy → Eisai ⓘ

CLARITY AD → sponsor → Eisai ⓘ

Eisai and Biogen → collaboratesWith → Eisai ⓘ

subject surface form: Biogen

EMERGE (Study 302) → coDeveloperCompany → Eisai ⓘ

ENGAGE (Study 301) → coSponsor → Eisai ⓘ

Donepezil → developedBy → Eisai ⓘ

Eisai → name → Eisai ⓘ